X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Biocon Ltd with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs ADCOCK INGRAM (S. Africa) - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON LTD   ADCOCK INGRAM
EQUITY SHARE DATA
    BIOCON LTD
Mar-18
ADCOCK INGRAM
Jun-14
BIOCON LTD/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,188365-   
Low Rs305264-   
Sales per share (Unadj.) Rs68.7108.7-  
Earnings per share (Unadj.) Rs7.6-27.4-  
Cash flow per share (Unadj.) Rs14.0-22.7-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.10-  
Book value per share (Unadj.) Rs86.385.3-  
Shares outstanding (eoy) m600.00168.78-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.92.9 375.4%   
Avg P/E ratio x98.9-11.5 -860.9%  
P/CF ratio (eoy) x53.4-13.9 -385.7%  
Price / Book Value ratio x8.63.7 234.5%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m447,90053,081 843.8%   
No. of employees `0006.14.3 143.2%   
Total wages/salary Rs m9,3113,331 279.5%   
Avg. sales/employee Rs Th6,705.84,273.4 156.9%   
Avg. wages/employee Rs Th1,514.2776.0 195.1%   
Avg. net profit/employee Rs Th736.9-1,076.8 -68.4%   
INCOME DATA
Net Sales Rs m41,23418,346 224.8%  
Other income Rs m2,062128 1,605.0%   
Total revenues Rs m43,29618,474 234.4%   
Gross profit Rs m8,291-3,179 -260.8%  
Depreciation Rs m3,851792 486.4%   
Interest Rs m615497 123.8%   
Profit before tax Rs m5,887-4,339 -135.7%   
Minority Interest Rs m213-12 -1,760.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569271 578.6%   
Profit after tax Rs m4,531-4,623 -98.0%  
Gross profit margin %20.1-17.3 -116.0%  
Effective tax rate %26.7-6.2 -426.5%   
Net profit margin %11.0-25.2 -43.6%  
BALANCE SHEET DATA
Current assets Rs m41,48613,437 308.8%   
Current liabilities Rs m21,4137,560 283.2%   
Net working cap to sales %48.732.0 152.0%  
Current ratio x1.91.8 109.0%  
Inventory Days Days64111 57.7%  
Debtors Days Days94124 76.0%  
Net fixed assets Rs m50,6617,832 646.8%   
Share capital Rs m3,00085 3,522.1%   
"Free" reserves Rs m48,8080-   
Net worth Rs m51,80814,399 359.8%   
Long term debt Rs m17,8985,060 353.7%   
Total assets Rs m99,89727,201 367.2%  
Interest coverage x10.6-7.7 -136.7%   
Debt to equity ratio x0.30.4 98.3%  
Sales to assets ratio x0.40.7 61.2%   
Return on assets %5.2-15.2 -34.0%  
Return on equity %8.7-32.1 -27.2%  
Return on capital %9.6-19.8 -48.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,7100-   
CASH FLOW
From Operations Rs m6,6211,566 422.8%  
From Investments Rs m-6,840-481 1,422.6%  
From Financial Activity Rs m-2,3974,592 -52.2%  
Net Cashflow Rs m-2,6125,678 -46.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.04 Rs / ZAR

Compare BIOCON LTD With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare BIOCON LTD With: CIPLA  WYETH LTD  STERLING BIOTECH  ALEMBIC LTD  MERCK LTD  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views On News

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Feb 15, 2019 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS